Actively Recruiting
BCI Training for Social Cognition and Error Monitoring in ASD
Led by University of Coimbra · Updated on 2025-08-01
28
Participants Needed
1
Research Sites
91 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Social cognition seems to develop atypically in autism, particularly in processes such as faces perception, joint attention and social information processing. In this sense, and using an Emotional Paradigm of Facial Expressions (EFP) with a Brain-Computer Interface (BCI) based on Electroencephalography (EEG), the investigators intend to evaluate its effectiveness as a medical device in Autism Spectrum Disorder (ASD), namely: improving 1) social skills and 2) reducing generalized anxiety, 3) improve error monitoring, and consequently verify 4) an increase in motivation. To this end, the investigators will test a gamified intervention (EFP), using personalized feedback in real time. In this gamified interface, there is an artificial agent that learns rules through Reinforcement Learning using the evoked potentials from the participant as they observe the agent's right or wrong actions. The hypothesis is that this approach allows, during the gamified task (EFP), not only the agent/interface to learn, but also the participant through operant conditioning and implicit scrutiny of errors, which makes it particularly interesting for disorders in which error monitoring processes are compromised, as in ASD.
CONDITIONS
Official Title
BCI Training for Social Cognition and Error Monitoring in ASD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant is able and willing to give written informed consent/assent
- Previous diagnosis of Autism Spectrum Disorder by a qualified clinician according to gold-standard instruments
- Aged between 16 and 55 years old
- Normal or corrected-to-normal vision
You will not qualify if you...
- Global Intelligence Quotient <70
- Dermatological diseases of the scalp
- Concurrent neurofeedback therapy
- Concomitant medication without a stable dosage for at least 4 weeks
- History of seizures and/or epilepsy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
ICNAS
Coimbra, Portugal, 3000 548
Actively Recruiting
Research Team
M
Miguel Castelo-Branco
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here